Company Filing History:
Years Active: 2013-2014
Title: Gabriele Stumm: Innovator in Protein Kinase Inhibitors
Introduction
Gabriele Stumm is a notable inventor based in Unterhaching, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for protein kinases. With a total of five patents to his name, Stumm's work has implications for various therapeutic applications.
Latest Patents
Stumm's latest patents include innovative approaches to inhibiting cyclin-dependent kinases. One of his inventions focuses on inhibitors of cyclin-dependent kinases and their therapeutic applications. This invention addresses methods for preventing and treating various conditions, including pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases, and neurodegenerative diseases. Another patent involves 4,6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases, which also targets similar therapeutic areas.
Career Highlights
Throughout his career, Gabriele Stumm has worked with prominent companies in the pharmaceutical industry. He has been associated with Ingenium Pharmaceuticals GmbH and AstraZeneca AB, where he has contributed to research and development efforts in drug discovery and therapeutic innovations.
Collaborations
Stumm has collaborated with several professionals in his field, including Philipp Wabnitz and Heike Schauerte. These collaborations have likely enhanced the scope and impact of his research.
Conclusion
Gabriele Stumm's work in the development of protein kinase inhibitors showcases his innovative spirit and dedication to advancing medical science. His contributions are paving the way for new therapeutic options in treating various diseases.